{"name":"Tiziana Life Sciences LTD","slug":"tiziana-life-sciences-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Foralumab Nasal","genericName":"Foralumab Nasal","slug":"foralumab-nasal","indication":"Moderate to severe ulcerative colitis","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Foralumab TZLS-401 100 µg","genericName":"Foralumab TZLS-401 100 µg","slug":"foralumab-tzls-401-100-g","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Foralumab Nasal","genericName":"Foralumab Nasal","slug":"foralumab-nasal","phase":"phase_2","mechanism":"Foralumab Nasal is an anti-CD3 monoclonal antibody that modulates the immune system.","indications":["Moderate to severe ulcerative colitis"],"catalyst":""},{"name":"Foralumab TZLS-401 100 µg","genericName":"Foralumab TZLS-401 100 µg","slug":"foralumab-tzls-401-100-g","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQTlhfdld3QnVtNU5hVGRkYTFxQ0EyeThCU0c3WmZtM2VQMDhYM1dPbUhnbE0zMllzVmRFSHlmV2pMVExnMWJBUXpwVXRwdHJUNWhmUzgxMkhncVVYNjNfclY3MmtLV2NfUnJyYmRuRHJUeVFkOGdDRTZZbHZ3UmEtSmRQcDlRcWppZW1mNWRJOU9Ba0ZDRml3TTY0VU00VU1P?oc=5","date":"2025-12-30","type":"pipeline","source":"Investing News Network","summary":"Discover the Top 5 Small-Cap Biotech Stocks in 2025 - Investing News Network","headline":"Discover the Top 5 Small-Cap Biotech Stocks in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOR3pVVTQwX3V5YmxUa2dqaVQzQXV0bGZNWXBZTjRmTzN2a0pPWnY2dDNuazRiWjVnbWNZNEhjM3Y0bV9Na0xPUzU3cnVHdFphSDZXWmRaamQxSzZEaDUxc3hnbFFwaHBXM0pTNkdBdTNaWkVMV0xidFppVFRacTliSWNhQlBNY083cUtSX2lGcnRhX2JuUTl4UFo1ejZ6SGdNaUF2QjNXNnNXVHlRaGp3a3ZCN3k4amZhSnR0M2hDTE0tUWVN?oc=5","date":"2025-12-15","type":"pipeline","source":"Proactive financial news","summary":"Tiziana Life Sciences withdraws proposed share offering - Proactive financial news","headline":"Tiziana Life Sciences withdraws proposed share offering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNdWt4dEN6TnNlZDMwVWNhOXB2UmVDN3ZFRXA4RWhIRVpIa2tPc0t4QkxodGY0QV9wODllTWNHRkgyYkxNTEx4ZjNUUDhYNngyOF9MNWJrSUpKSzFUajYyRTdxbGFpU2RtOXc1cjlOQ2QwU0t0T3dhb2JuZXE0d0VmODNvd1MxUTVLUUZNb3Y0bGJsWDlhbDU1YVk1V0VsdHRnVW0zOW82dUJZUXZOamRpY0JrQWVVSkw5aDBfZlBCazM4a0lfc0E?oc=5","date":"2025-12-15","type":"pipeline","source":"Proactive financial news","summary":"Tiziana CEO boosts stake with open-market share purchase - Proactive financial news","headline":"Tiziana CEO boosts stake with open-market share purchase","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNLXBsSUJmZ0l0M3pkNnJid0Y5LW1XVjM3LWFRSVcta3NTRGZtNFl2Zlk2aEw1bW9GUXFKbXF0dkRSajg5N0tYSVR3TUNqWE1jSzVSY3h3bFRtcnV6Z01MSmxxNUEzbElpZTFqT2hxUU1sREV2X2tGVXAtUDEtaHd3VVlXeXRiZjdRaVJ2dkxyMDU0c2VtVklfSGd5ckkxTWVNWTRYa0JQendUVWR2?oc=5","date":"2025-10-31","type":"pipeline","source":"seekingalpha.com","summary":"Tiziana Life Sciences: Foralumab's Intranasal Push Is A Good Moonshot (NASDAQ:TLSA) - seekingalpha.com","headline":"Tiziana Life Sciences: Foralumab's Intranasal Push Is A Good Moonshot (NASDAQ:TLSA)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxORDU1STg1S1VuTWZtV0YxNDJlRklDcmxIMGRBRTNwcm9YMkZYQXVFRTdoY09EaTJoTVA4WHJnd1BBcmduR1VwWVJQLVBQcWF3UzFqQ0hEQnRVN29aZTVZQVpJQ3lhLWFmYWI3djVYLVh2TmhBbzhsZ3NwbzhSRWNpZlJCX2RrajJleFE?oc=5","date":"2025-09-13","type":"pipeline","source":"TIKR.com","summary":"9 of the Fastest-Growing Biotech Stocks Under $10 Billion - TIKR.com","headline":"9 of the Fastest-Growing Biotech Stocks Under $10 Billion","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-22","type":"pipeline","source":"simplywall.st","summary":"Promising Penny Stocks To Watch In July 2025 - simplywall.st","headline":"Promising Penny Stocks To Watch In July 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxQbGdvVFdOQkQyQ016WmtQQ2ZTRU81cWE1VnFFNnFMd2t5bU41Nzh6UURXcVk1YkRHWGkxYlFsMzU1U3VKYnBobGgxSUNBRXZ2VmZiaXhqUnRsclhZbTBIVURxSlF0UmZDM3I4R2E2M0pqcUdSRTdDdDlJdi16QjBCZWU2SzJlalVnXzd1M2kyVFVBaDZ0Rmp1ZlBDeEUtY0FSOHUzN1hiSjAtSWdXN1NWQnZDTE9nbXJGb1VSUkdEQmJFV1ZTcTRkb3lVMVFkcWJyM1ljQTBYSWh1M3BwaTBoMFFVYWJuRHNTYlNjNA?oc=5","date":"2025-04-15","type":"pipeline","source":"PR Newswire UK","summary":"Takeda's ENTYVIO Continues Growth Trajectory in Ulcerative Colitis and Crohn's Disease | DelveInsight - PR Newswire UK","headline":"Takeda's ENTYVIO Continues Growth Trajectory in Ulcerative Colitis and Crohn's Disease | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNQ3c0R3lyWG9ieURmR01JUS1zV3RFS2VaaW1GNUJobXBfR0NhYnZNdWJwYzhYcmhPX0VIb1RFQ054WHpKLVVYUTJ2amxzX3Q2TVRSWmJrZ29rakpNQl9wUURONm1fclN3MGQwWV9QUWJPM0E4YTVRN0l0NFlmQkVxd05ManBlRDRKSjZMUF9tb2xnVVhfYUtDTGw4STBvNnlkUm8zQ3E1Tm9rM3paQVBtNmlwREpiVlAy?oc=5","date":"2025-02-21","type":"deal","source":"Contract Pharma","summary":"Tiziana Life Sciences & Renaissance Partner on Nasal Foralumab Production - Contract Pharma","headline":"Tiziana Life Sciences & Renaissance Partner on Nasal Foralumab Production","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxNYVZGb1d4SlV6bHhTQ0RSVURidk9lekxZR0JyZlM1OEFCcmNBcnpaNGZCZzdybERwZFNjb2VSSjJmWXJpdUMwbWMxZW93ZXY0SV8wUDRBSVRaaFRxeFpPNXFCZ3JqQUpwbEtWdFNEY2lPYURISVF2QmV4aG8zdmw0dlpxV0RFT3VnV29fRmdkdDd3WkVrM1VJaU5rb0J3aHdGbkhGeE0yRFM4clBOQWxGT0JaTFcxS3VlVHZzNHU1YjlhQlEtcG1OUjlzdEp1QjU5RlNBeXNlcHZJLVl6SVBONkdkTQ?oc=5","date":"2024-11-13","type":"pipeline","source":"prnewswire.com","summary":"75+ Key Companies Charting New Frontiers in Multiple Sclerosis Therapeutic Space | DelveInsight - prnewswire.com","headline":"75+ Key Companies Charting New Frontiers in Multiple Sclerosis Therapeutic Space | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFBFVHFlWTJPLXFEeUM1MlY3cEIzSXdid25JYVFHUGZhQ2s2dHZKYmVMaThWZzdTZHpnbEtYcHdfTS1FcmhueUhRQUVmSi1ReVJ3X0E?oc=5","date":"2019-03-11","type":"pipeline","source":"Yahoo Finance Australia","summary":"Tiziana Life Sciences Ltd (TLSA) stock price, news, quote and history - Yahoo Finance Australia","headline":"Tiziana Life Sciences Ltd (TLSA) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE8tb3U0UUpBaGtpTHBJY25mejhQUldURVlXUkVlb20xQ1lyaVExaVNWV21iTXlhZ0QteTRneWs0aWFPWE1PZTNsV19Ja3k5NTlSbElheWtiTUdxUXl1?oc=5","date":"2018-10-28","type":"pipeline","source":"TradingView","summary":"TLSA Stock Price and Chart — NASDAQ:TLSA - TradingView","headline":"TLSA Stock Price and Chart — NASDAQ:TLSA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQTENQMmxaSGhVT2tPRkh5NkJFdTY1R2RaUlB0SmRQNVExU012dUxrWVhRNlhOdWVZUkVvdjE1TmVyYVI4OHNNdHhGYnkxYkxJRGx0ZURpbWpVSGlEUW9MRGEtdFdYUUotWThQazdRU1o2a1lsNFhTWFhpam5Samg4NUx1c2l1bUhIT25ZU2ZvYnFjQUFKMlhwNXpYT1RDVE1fd2k4cmZCYWVuaUdVdmZ6bTZnLUVQakk?oc=5","date":"2014-09-12","type":"pipeline","source":"Drug Target Review","summary":"Scientific founder of Intercept Pharmaceuticals joins Tiziana Life Sciences - Drug Target Review","headline":"Scientific founder of Intercept Pharmaceuticals joins Tiziana Life Sciences","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}